Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Stomach Neoplasms 83Pancreatic Neoplasms 26Esophageal Squamous Cell Carcinoma 10Esophageal Neoplasms 10Biliary Tract Neoplasms 10Colorectal Neoplasms 9Neoplasm Metastasis 7Nasopharyngeal Carcinoma 5Cholangiocarcinoma 5Colonic Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Recurrence 3Head and Neck Neoplasms 3Advanced Pancreatic Cancer 3Rectal Neoplasms 2NSCLC 2Locally Advanced Pancreatic Cancer 2Locally Advanced Gastric Cancer 2Gastrointestinal Neoplasms 2Gastric Cancer Peritoneal Metastases 2Advanced Non-Small Cell Lung Cancer 2Advanced Gastric Cancer 2Adenocarcinoma 2mCRC 1Surgically-Created Resection Cavity 1Stage IV Gastric Cancer With Metastasis 1Squamous Cell Carcinoma of Head and Neck 1Progression Free Survival 1Preventive Effect of Quintuple Therapy on Metachronous Liver Metastases in Patients With Colorectal Cancer 1Pancreatic cancer, adult 1

Interventions

Trastuzumab 304Paclitaxel 257Cyclophosphamide 251Docetaxel 238Capecitabine 176Letrozole 163Carboplatin 163Fulvestrant 145Doxorubicin 145Bevacizumab 121Anastrozole 106Tamoxifen 102exemestane 94Vinorelbine 91Epirubicin 90pertuzumab 89Gemcitabine 84Lapatinib 80Albumin-Bound Paclitaxel 74Radiotherapy 71pembrolizumab 70palbociclib 64130-nm albumin-bound paclitaxel 58eribulin 56Cisplatin 55Everolimus 49pyrotinib 45Taxes 44Goserelin 43Neoadjuvant Therapy 40

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Breast Neoplasms × S 1 (combination) × Clear all
NCT00438100 2015-05-29

Capecitabine vs. S-1 in Unresectable or Recurrent Breast Cancer

Japan Breast Cancer Research Network

Phase 2 Completed
142 enrolled 4 charts
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡